Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company - STAA

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 04:37pm EDT

NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether STAAR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On May 3, 2019, STAAR disclosed receipt of a letter from the Center for Devices and Radiological Health of the U.S. Food and Drug Administration (“FDA”) regarding its review of the Company’s premarket approval application (“PMA”) supplement regarding EVO/EVO+ Visian Implantable Collamer Lens for Myopia and EVO/EVO+ Visian Toric Implantable Collamer Lens for Myopia with Astigmatism.  In the letter, the FDA specifically “advised the Company that its PMA supplement lacked information, particularly the clinical evidence and analysis, that would permit the completion of the review and determination of whether there is a reasonable assurance of the device’s safety and effectiveness for its intended use.” 

On this news, STAAR’s stock price fell $3.15 per share, or 11.19%, to close at $25.00 per share on May 3, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
11:08aBOEING : GKN Fokker Services and Spectralux sign an exclusive distributor agreement
AQ
11:08aAPPLIED DNA SCIENCES : Raises $1.5 Million In Secured Convertible Notes
BU
11:06aPLUNGERHEAD WINES : Partners with First Responders Children's Foundation
BU
11:05aGOLDON RESOURCES : Selected Rock Grab Samples Assay up to 292.94 g/t Au and 2,141 g/t Ag at Slate Falls Project
PU
11:05aPUBLIC SERVICE : PSEG Long Island Prepared to Meet Customer Demand in Extreme Heat
PU
11:05aBANCO DO BRASIL : 07/17/2019 Information to the Market – Earnings Release and Quiet Period – 2Q19
PU
11:05aGAZPROM EDR : Gas-powered KAMAZ finishes among top five trucks in Silk Way International Rally 2019
PU
11:05aASSURA : Persons Discharging Managerial Responsibilities
PU
11:04aGlobal ECG Sensor Patch Market to Surpass US$ 299.3 Million by 2026
BU
11:03aGSMA : Signs £38 Million Funding Partnership With the Department of International Development
BU
Latest news "Companies"
Advertisement